Author(s): Pfaus JG; Antonie RA; Dosa PI; Kim SW;

Rationale: Cabergoline (CAB) is an ergot derivative typically prescribed for the treatment of hyperprolactinemia. It suppresses the release of prolactin through agonist actions on dopamine (DA) D2 receptors; however, it possesses binding affinity for other ...

Article GUID: 37968530